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Abstract
Background: The amplification of signals, defined as an increase in the intensity of a signal through
networks of intracellular reactions, is considered one of the essential properties in many cell
signalling pathways. Despite of the apparent importance of signal amplification, there have been few
attempts to formalise this concept.
Results: In this work we investigate the amplification and responsiveness of the JAK2-STAT5
pathway using a kinetic model. The recruitment of EpoR to the plasma membrane, activation by
Epo, and deactivation of the EpoR/JAK2 complex are considered as well as the activation and
nucleocytoplasmic shuttling of STAT5. Using qualitative biological knowledge, we first establish the
structure of a general power-law model. We then generate a family of models from which we select
suitable candidates. The parameter values of the model are estimated from experimental
quantitative time-course data. The final model, whether it is conventional model with fixed
predefined integer kinetic orders or a model with variable non-integer kinetic orders, is selected
on the basis of a good agreement between simulations and the experimental data. The model is
used to analyse the responsiveness and amplification properties of the pathway with sustained,
transient, and oscillatory stimulation.
Conclusion:  The selected kinetic model predicts that the system acts as an amplifier with
maximum amplification and sensitivity for input signals whose intensity match physiological values
for Epo concentration and with duration in the range of one to 100 minutes. The response of the
system reaches saturation for more intense and longer stimulation with Epo. We hypothesise that
these properties of the system directly relate to the saturation of Epo receptor activation, its low
recruitment to the plasma membrane and intense deactivation as predicted by the model.
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Background
Cellular signal transduction is accomplished by networks
of interacting proteins that detect, modulate and transfer
cellular signals which control gene expression. A prime
example of this is tumour progression and certain onco-
genic processes, which directly relate to dysfunctions in
signal transduction networks [1,2]. So far the use of math-
ematical modelling in cell signalling has been limited by
the availability of suitable experimental data. However,
the systematic development of experimental techniques
enabling the generation of time-resolved quantitative data
[3-5] facilitates the identification of dynamic pathway
models and their parameter values by fitting them to
experimental time course data.
The amplification of signals is considered one of the
essential properties in most of the cell signalling pathways
[6]. The notion of amplification as an increase in the
intensity of the signal through the signalling cascade is
generally accepted and used to characterise such systems.
Surprisingly, there is little work in which a formal defini-
tion of amplification is proposed and used together with
mathematical models to analyse signalling systems [7-
10].
The Janus kinase – signal transducer and activator of tran-
scription (JAK-STAT) pathways are one of the best-studied
cell signalling pathways [11,12]. The JAK2-STAT5 path-
way is activated through various receptors, including the
erythropoietin receptor (EpoR). Cytokine-activated phos-
phorylation of EpoR is mediated by the cytosolic kinase
JAK2 which is associated with the cytoplasmic domain of
EpoR. Upon binding of the hormone erythropoietin
(Epo), JAK2 is activated and phosphorylates several tyro-
sine residues within the cytoplasmic domain of EpoR
[13]. Subsequently, the transcription factor STAT5 is
recruited to the activated receptor, becomes phosphor-
ylated and thereby gets activated. Upon activation STAT5
homodimerises and migrates to the nucleus, where it ini-
tiates the transcription of target genes (see Figure 1 for a
simplified representation of this pathway).
Previous work on data-based mathematical modelling of
the core module of the JAK2-STAT5 signalling pathway
[14] revealed nucleocytoplasmic cycling as an essential
building principle of this pathway to closely couple gene
transcription to receptor activation. Sensitivity analysis of
the model showed that, surprisingly, not the first step of
the pathway, i.e. phosphorylation of STAT5 at the recep-
tor, but the parameters describing the shuttling through
the nucleus have the major influence on transcription.
The prediction of the outcome of an independent experi-
ment based on this theoretical finding could be con-
firmed. Analysis of the model variables, i.e.
unphosphorylated and phosphorylated monomeric
STAT5 in the cytoplasm, and dimeric STAT5 in the cyto-
plasm and the nucleus, demonstrated that in a first round
of activation nearly all accessible STAT5 molecules are
phosphorylated. Thereby, it was shown that nucleocyto-
plasmic shuttling serves as a recycling step for the limited
pool of STAT5 molecules, thus identifying an implemen-
tation of the strategies used by the cell to save energy and
resources. The present paper extends this previous work
by including a simplified description of the dynamics of
EpoR at the plasma membrane (recruitment, degradation,
and deactivation) and by analysing amplification and
responsiveness of the pathway.
As an alternative to models that are derived on the basis of
conventional mass action kinetics with predefined fixed
Structure of the JAK2-STAT5 pathway model proposed Figure 1
Structure of the JAK2-STAT5 pathway model pro-
posed. Legend: Epo: concentration of Epo in the extracellu-
lar medium; EJ: fraction of non-activated EpoR/JAK2 
complex; pEpJ: fraction of activated EpoR/JAK2 complex; S: 
fraction of non-activated and non-dimerised STAT5 in the 
cytosol; DpS: fraction of activated and dimerised STAT5 in 
the cytosol; DpSnc: fraction of activated and dimerised STAT5 
inside the nucleus.BMC Systems Biology 2008, 2:38 http://www.biomedcentral.com/1752-0509/2/38
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integer kinetic orders, we use a more general power-law
formulation that allows for non-integer kinetic orders
[15] with the following structure:
Where Xi represents any of the nd dependent variables of
the model (e.g., proteins or phosphoprotein concentra-
tions or levels of gene expression). Here, the biochemical
rate j is expanded as a product of a rate constant (γj) and
the p variables of the system to characteristic kinetic orders
(gjk), while cij are the stoichiometric coefficients of the sys-
tem describing mass conservation. The main difference
between power-law models and conventional ODEs mod-
els used in systems biology is that kinetic orders can have
non-integer values. There are two main reasons to allow
non-integer kinetic orders: firstly, reactions in non-
homogenous environments lead to non-integer kinetic
orders [16-18] and secondly in the absence of data on the
detailed reaction mechanisms one is often forced to con-
dense several steps into simplified representations. This
aggregation of information is conveniently represented by
power-law expressions, although other alternatives are
possible [19,20]. In power-law models, the kinetic orders
are parameters of the model and must be estimated from
experimental data. Negative values for the kinetic order
represent inhibition, while a zero indicates that the varia-
ble does not affect the described process. When positive
values are considered for a kinetic order, several alterna-
tives are possible: values between zero and one represent
a saturation-like behaviour for the rate modelled, and
with values higher than one the rate equation models
cooperative processes. A kinetic order equal to one means
that the system behaves like conventional mass-action
kinetic model. By allowing non-integer, positive or nega-
tive, kinetic orders we consider for the same model struc-
ture a larger class of kinetic models from which we can
select a suitable candidate.
However, the increased generality comes at a price when
it comes to the estimation of parameter values from exper-
imental data for larger networks. While for conventional
models the kinetic orders are decided a priori, in power-
law representations the number of parameters that must
be extracted from data is therefore larger. The identifiabil-
ity problem means that there could be multiple sets of
parameter values for which the model fits the data equally
well. Analytical approaches for the inference of identifia-
bility are limited to rather low dimensional systems [21],
while approaches that are applicable to large systems
[22,23] rely on linearisation that question their reliability.
Recent results based on non-parametric bootstrap-based
approaches [24] will allow for reliable identifiability anal-
ysis also for high dimensional systems.
Next, we discuss the structure and equations of the math-
ematical model proposed and the process by which
parameter values were estimated. In addition, we per-
formed a model-based analysis of the responsiveness and
amplification of the system, for which we propose a for-
mal definition of these variables. The experimental and
computational methods used to set up the model for the
JAK2-STAT5 pathway are summarised at the end of the
manuscript.
Results and Discussion
Mathematical Model and Parameter Estimation
In our model, EpoR and JAK2 were assumed to form a sta-
ble complex, EpoR/JAK2, for all biochemical processes
included. All variables in the model describing the consid-
ered states of EpoR refer to populations of the receptor at
the plasma membrane. Based on experimental data
obtained during our investigation (data not shown), we
assume in our model that the dynamics of the intermedi-
ate state of the receptor in which only JAK2 is activated is
negligible in the description of the system. Thus, two pos-
sible states for the EpoR/JAK2 complex were considered: i)
EpoR/JAK2 not bound to Epo, EJ; and ii) activated Epo-
bound EpoR/JAK2 complex, pEpJ. The receptor activation
was modelled with a term depending on the Epo concen-
tration and the amount of non-activated receptor complex
at the plasma membrane   A rate equa-
tion accounting for the degradation of activated Epo
receptor was also included in the model. Since the koff of
the Epo binding to the human EpoR is much smaller than
the kon [25], we assumed that effects of the release and
reactivation of the related murine EpoR can be neglected,
which was also tested in preliminary models. Actually, ini-
tial explorations considering the reactivation of EpoR
were not consistent with the experimental data used in
this work (data not shown). The structure of the model
was completed by the inclusion of terms that describe the
recruitment of new EpoR/JAK2 complexes to the plasma
membrane and the degradation of non-activated EpoR/
JAK2 complexes.
Three possible states have been considered for STAT5 in
the model: i) non-activated and monomeric STAT5 in the
cytosol, S; ii) activated STAT5 in the cytosol, DpS; and iii)
activated STAT5 in the nucleus, DpSnc. STAT5 activation
comes through phosphorylation and dimerisation. Our
preliminary results suggested that dimerisation is a fast
d
dt
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processs and therefore the slower phosphorylation of
STAT5 in the receptor complex leads the activation proc-
ess. Thus, model reduction was applied and the aggrega-
tion of both processes was then represented with a unique
rate equation ( , see Additional file 1).
Since the dimerisation of STAT5 is considered a fast proc-
ess, the model assumes that the protein dimerises imme-
diately after monomeric phosphorylation and the
variable that describes monomeric phosphorylated STAT5
is neglected. We note that STAT5 can only be considered
activated after the dimerisation of two phosphorylated
monomers. Experimental data describing the transloca-
tion of activated STAT5 to the nucleus and its dynamical
behaviour inside the nucleus are currently not available,
and therefore the differential equations describing such
processes have not been formulated in detail. Thus, we
model the fraction of STAT5 inside the nucleus with a sin-
gle state variable. The processes considered in the model
are the activation of STAT5 by the activated receptor com-
plex EpoR/JAK2, the translocation of cytosolic activated
STAT5 to the nucleus, and the deactivation and subse-
quent translocation of nuclear STAT5 back to the cyto-
plasm. In accordance with [14], only nuclear activated
STAT5 can be deactivated in our model. The total amount
of STAT5 is supposed to be constant.
Finally, the concentration of Epo in the extracellular
medium, Epo, is considered the input signal of the system.
The resulting model has five dependent variables and one
input variable. Figure 1 illustrates the structure of the
model proposed. Only the states of the proteins and the
processes that have been discussed are included. The dif-
ferential equations for the model were formulated using
power-law terms:
In this model we assume that, after the long period of star-
vation before starting the experiment, the system reaches
a steady-state level of EpoR at the plasma membrane.
Under these conditions and in the absence of stimulation,
there is equilibrium between receptor recruitment and
degradation, which makes the rate constants in both
terms (recruitment rate and first order degradation for the
receptor) equal for the normalised variables used in the
model. The effect of the dimerisation process was also
considered in the formulation of the equations, which
leads to stoichiometric coefficients of value two in Equa-
tion (3.3). Following the ideas proposed in [14], a possi-
ble delay, τ, was included in the rate that describes the
deactivation of DpSnc in the nucleus and subsequent trans-
location to the cytosol.
The experimental data available were converted into the
normalised scale [5] defined in Sup. Mat. A1 [see Addi-
tional file 1]. Data from two replicate experiments were
available and used as independent experiments for
parameter estimation. In these experiments, the cytoplas-
mic concentration of activated STAT5, [pSTAT5cyt], and
the concentration of activated EpoR/JAK2 complex,
[pEpoR], were measured in several time points. Addition-
ally, the extracellular concentration of Epo, [Epo], was
measured in an independent equivalent experiment.
Additional algebraic equations, reflecting the relation
between the measured quantities (observables) and the
variables, were defined in the model:
[Epo] = Epo [pEpoR] = pEpJ [pSTAT5cyt] = 2·DpS (4)
The variables on the left-hand side represent the observa-
bles, while the right-hand side represent the variables con-
sidered in the model. Further details on data processing
are discused in Sup. Mat. A2 [see Additional file 1]. Several
models were tested, including models with fixed prede-
fined integer kinetic orders, with and without time delay
in the STAT5 cycling, and several models with an increas-
ing number of variable non-integer kinetic orders. In this
latter case, variable non-integer kinetic orders related to
terms representing a higher simplification of the dynam-
ics were tested first (EpoR and STAT5 activation) and after
that, the number of terms with non-integer kinetic order
was systematically increased. The best compromise
between an appropriate data fitting and a suitable number
of parameters to be estimated was a model with fixed inte-
ger kinetic orders and no explicit time-delay for DpSnc
deactivation. Note, that although the chosen model here
has no time delay as in [14], there is no contradiction
g 5
67 ⋅⋅ S pEpJ
gg
d
dt
EJ EJ Epo EJ
gg g =−⋅ ⋅ −⋅ gg g 12 1
12 3 (3.1)
d
dt
pEpJ EJ Epo pEpJ
gg g =⋅ ⋅ −⋅ gg 23
12 4 (3.2)
d
dt
S DpS t S pEpJ nc
g gg =⋅ ⋅ − () () −⋅ ⋅ ⋅ 22 45
5 67 gt g
(3.3)
d
dt
DpS S pEpJ DpS
gg g =⋅ ⋅ −⋅ gg 56
67 8 (3.4)
d
dt
DpS DpS DpS t nc
g
nc
g
=⋅ −⋅ − () () gg t 64
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between the two models. We do not represent the time
delay implicitly but here we have a new state variable
DpSnc representing the fraction of activated STAT5 in the
nucleus. The power-law model with non-integer kinetic
orders for the term describing EpoR/JAK2 complex activa-
tion fitted the available data better (the objective func-
tion, Fobj, is 20% smaller than in the kinetic model), but
the limited improvement obtained did not justify the
choice of this model and we therefore followed the parsi-
mony principle and selected the simpler and yet satisfac-
tory model with fixed predefined integer kinetic orders.
The procedure used and the different options analysed are
discussed in Sup. Mat. A2 [see Additional file 1]. In all
cases, parameters were computed for biologically relevant
intervals in the parameter space using a genetic algorithm.
The parameter values for the chosen model as well as the
initial conditions used for parameter estimation are sum-
marised in Table 1.
The model trajectories obtained for the chosen solution
are depicted in Figure 2. The general behaviour of the sys-
tem is reproduced despite the fact that the differences
between the data obtained in the two replicates of the
experiment are significant for some time points. We
notice that the dynamics of phosphorylated EpoR is much
better delimited by the experimental data and therefore
the fit of the data is much clearer. The fit is also quantified
with the objective function described in Equation 2 in
Table A3 in Sup. Mat. A2 [see Additional file 1].
Data fitting of the selected solution for the observables Figure 2
Data fitting of the selected solution for the observables. A: activated EpoR, [pEpoR]. B: activated cytosolic STAT5, 
[pSTAT5cyt]. Data from two replicates were used as independent experiments. The quantitative data obtained from the two 
experiments (data points represented as crosses for experiment 1 and points for experiment 2) are compared with the solu-
tion of the model identification process (lines). Experimental data were obtained from BaF3-EpoR cells (proB cells exogenously 
expressing the murine EpoR) stimulated with 5 units/ml Epo and normalised as defined in Sup. Mat. A1 [see Additional file 1].
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Table 1: Values of the parameters in the selected solution
Parameter g1 - g8  τ
Value 1 0
Parameter γ1 γ2 γ3
Value 0.0025 (± 0.0004) 0.2531(± 0.0006) 0.0175 (± 0.0092)
Parameter γ4 γ5 γ6
Value 0.4674 (± 0.0136) 0.3631 (± 0.0102) 0.454 (± 0.0151)
Parameter Epo(t = 0) EJ(t = 0) pEpJ(t = 0)
V a l u e 110
Parameter S(t = 0) DpS(t = 0) DpSnc(t = 0)
V a l u e 100BMC Systems Biology 2008, 2:38 http://www.biomedcentral.com/1752-0509/2/38
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Analysis of Amplification
To analyse how the signal is amplified through the path-
way, we define the logarithmic amplification factor (LA)
between two activated intermediates in a signalling path-
way X* and Y* (with Y* downstream in the pathway) with
the following equation:
Where T is the duration of stimulation, LA is the logarithm
of the ratio between the total productions of both inter-
mediates during the signalling process considered. The
total production of an intermediate is described by the
integral of the net activation rate during the stimulation
process. Considering this definition, a system amplifies
between two steps in the pathway when LA is higher than
zero. If LA is smaller than zero, the system provokes an
attenuation of the signal. In the scale proposed, a value of
one for LA implies that on average each molecule of X*
produces ten molecules of Y*, while a value of minus one
represents that ten molecules of X* produce on average
one molecule of Y*. In Table 2 we propose a classification
in significant intervals for the value of LA in terms of the
ability of the system to amplify.
In order to analyse the responsiveness and the ability of
the system to amplify signals, the performance of the sys-
tem was analysed via mathematical simulation assuming
three different conditions: sustained stimulation, tran-
sient stimulation and oscillatory stimulation by Epo. In
case of a sustained stimulus, we analysed the response of
the system in terms of the steady-state induced in the sys-
tem for different values of constant Epo concentration in
the extracellular medium, Eposs, from very low concentra-
tions, Eposs = 10-8 units/ml, to concentrations up to ten-
fold the initial concentration used in the experiments
performed, Eposs = 50.0 units/ml. Under normal condi-
tions, the physiological serum concentration of Epo in
mice is 7.9·10-3 units/ml [26]. We have computed the
steady-state values of DpSnc and they are shown in Figure
3. The logarithmic scale was used for the values of Eposs.
The figure shows clearly a sigmoidal behaviour in the log
scale of Eposs. We can see that the system maximally
responds to changes in concentration of Epo in the inter-
val 10-3-10-1, which includes the normal range of Epo con-
centration in mouse serum (the behaviour is similar in
case of pEpJ [see Additional file 1]). For smaller sustained
stimuli the system is not significantly activated, while for
intense stimuli the system reaches saturation and
becomes virtually insensitive to any increase in the stimu-
lus. Similar behaviour has been previously described as a
typical feature of amplifying signal transduction pathways
[7]. We analysed also the logarithmic amplification factor,
LA, between the activated receptor, pEpJ, and the activated
dimerised STAT5 in the nucleus, DpSnc. The total produc-
tion in steady-state is described by the integral of the net
activation rate of the considered intermediate. If we use
the suggested definition in this case, we obtain the follow-
ing:
LA
V
Y
td t
T
V
X
td t
T =
∗
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∗
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⎛
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Steady-state values of DpSnc (DpSnc,ss) for different values of  sustained stimulation on Epo (Eposs) Figure 3
Steady-state values of DpSnc (DpSnc,ss) for different 
values of sustained stimulation on Epo (Eposs). The 
dashed black line indicates the physiological value for serum 
concentration of Epo (aprox. 7.9·10-3 units/ml), while the 
finely dashed line indicates the concentration of Epo used in 
the experiments performed (5 units/ml).
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Table 2: Classification for the values of logarithmic amplification 
(LA) in significant intervals
LA < -1 Strong attenuation
-1 <LA < 0 Attenuation
0 <LA < 1 Amplification
LA > 1 Strong amplificationBMC Systems Biology 2008, 2:38 http://www.biomedcentral.com/1752-0509/2/38
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where   is the steady-state value of   and 
is the steady-state value of   for the considered sus-
tained concentration of Epo. RSTAT5/EJ is the ratio between
the total amount of STAT5 and total amount of the EpoR
at the cell surface. Since in our model we use normalised
units, this ratio must be calculated in order to quantify the
real value of amplification. The preliminary estimates for
this ratio in the investigated cell line assigns a value
around RSTAT5/EJ = 10 (data not shown). The inclusion of
this factor is useful in order to quantify the numerical
value of the amplification (it is acting as a translation fac-
tor in the LA-axis), but the rest of properties of the LA
function (shape of the curve, scale, position of maxima
and minima) depend on the intrinsic properties of the
model and are not affected by the value of this ratio (LA is
a logarithmic property; further explanations in Sup. Mat.
A3 [see Additional file 1]). The definition in Equation
(7.1) is valid for any kind of stimulus applied to the sys-
tem (sustained, transient or oscillatory), while Equation
(7.2) is the specific formulation for a sustained stimulus.
Figure 4 shows the results obtained for the considered
interval of sustained stimulus. The logarithmic amplifica-
tion factor has a value slightly higher than two (LA = 2) for
all different values of sustained stimulation simulated,
which implies an intense amplification of the signal.
Thus, our model predicts that an activated receptor can on
average activate and induce the nuclear translocation of
up to 125 units of STAT5 before its deactivation. In addi-
tion, the maximal increase in amplification is in the inter-
val 10-4-10-1; smaller stimuli produce a higher
amplification, which implies that the system reacts sensi-
tively to weak stimulation.
In case of a transient stimulus, the stimulation by Epo was
characterised by two properties: the average duration of
the stimulus, TEpo, and the average value of the Epo con-
centration during transient stimulation, Epotr. In both
cases we adapted the definitions proposed in [8] (a com-
plete description is available in Sup. Mat. A4 [see Addi-
tional file 1]). Moreover, the variables considered for the
analysis of a transient stimulation were the average
amount of pEpJ (pEpJtr) and DpSnc (DpSnc,tr) during the
stimulation, which are the transient stimulation "equiva-
lent" for Eposs and DpSss. In the simulations, the initial
values for the variables were consistent with the initial
conditions (representing conditions after serum starva-
tion) used in data fitting (Sup. Mat. A1 [see Additional file
1]). The stimuli analysed had a duration between 0.1 and
104  minutes and an average stimulus concentration
between 10-6 and 500 units/ml:
TEpo ∈ [0.1, 104] min Epotr ∈ [10-6,500] units/ml (8)
Figure 5 shows the response of the system in DpSnc,tr when
transient stimulation of the system with the properties
stated were simulated and analysed (Sup. Mat. A6
includes the figures on pEpJ [see Additional file 1]). The
system reaches maximum average activation for stimuli
with average intensity, Epotr, higher than 0.01 and average
duration, TEpo, between approximately 10 and 100 min-
utes. For longer stimulation, even at very high concentra-
tions of Epo, there is a significant loss in DpSnc,tr. For
input signal longer than 500 minutes there is a partial
recovery of the average signal intensity DpSnc,tr and a pla-
teau finally appears (which is even more apparent for
pEpJtr [see Additional file 1]) for very long stimulation,
which means that the system is not able to produce
stronger responses for more intense stimuli. We suggest
that this behaviour relates to the effect of limited recruit-
ment of new EpoR to the plasma membrane, which is
unable of faster recovery after very intense stimulation.
We notice that is special features of the figure appear even
for other computed solutions (data not shown) and
seems to be a structural property of the model. In the
V EJ Epo V S pEpJ pEpJ DpSnc
++ =⋅⋅ =⋅ ⋅ gg 25 (7.3)
VpEpJ
SS + VpEpJ
+ VDpS
SS
nc
+
VDpSnc
+
Logarithmic amplification, LA (log. units, see Equation 7.1), for  different values of sustained stimulation with Epo (Eposs) Figure 4
Logarithmic amplification, LA (log. units, see Equa-
tion 7.1), for different values of sustained stimulation 
with Epo (Eposs). LA measures the signal amplification 
between pEpJ and DpSnc. The dashed black line indicates the 
physiological value for serum concentration of Epo (aprox. 
7.9·10-3 units/ml), while the finely dashed line indicates the 
concentration of Epo used in the experiments performed (5 
units/ml).
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range of the Epo pulse duration (TEpo) between 1 and 100
minutes and for average stimulus concentration (Epotr)
around the physiological values, [5.10-3, 5.10-1], the sys-
tem shows maximum sensitivity to changes in the proper-
ties of the input signal. We furthermore investigated the
responsiveness of the system predicted by the model with
respect to the total amount of stimulus provided (Epotot),
which in our simulations is represented by the product
Epotot = Epotr · TEpo (Sup. Mat. A4 contains further expla-
nations [see Additional file 1]). Figure 6 shows our results,
which condense the information depicted in Figure 5. The
characteristic sigmoid-like behaviour of the model is also
visualised in this figure. In addition, when a low stimulus
is provided, the average response of the system (repre-
sented by DpSnc,tr) does not depend on the features of the
transient stimulus and stimulation with different duration
and average intensity but the same total amount of Epo
produces an almost identical response (Figure 6). In con-
trast, for a larger stimulus the response of the system will
depend on the features of the input signal: different sig-
nals with the same total amount but different duration or
average intensity will produce responses that can differ on
average in ± 0.05 normalised units for DpSn,trc, that is 50%
of the average value (see solid black line in Figure 6).
Interestingly, in case of medium and high Epotot, there is
for any value of DpSnc,tr an interval of values for Epotot in
which signals that differ in all their properties will pro-
duce the same average output signal.
When we analysed the logarithmic amplification for a
transient stimulus (Figure 7), we found that the range of
values is again reduced but the average value is higher
than two. The minimum amplification is reached for a
transient stimulus with intermediate duration and high
intensity, while the system shows a higher factor of ampli-
fication for short, weak stimulation in accordance with
the results obtained for sustained stimulation. The maxi-
mum sensitivity of the amplification factor to changes in
the signal is in the interval previously determined (TEpo ∈
[1,500 min], Epotr ∈ [5.10-3, 5.10-1])
The dynamics of the system with oscillatory Epo concen-
tration were also considered. For simulations, we did not
choose perfect sinusoidal oscillatory signals but a design
based on truncated triangular signals (Sup. Mat. A5
includes further explanations [see Additional file 1]). In
[27] a physiological daily oscillation of the Epo concen-
tration in the blood is described in which Epo is main-
tained at an almost stable value during daytime but
reduces to half its value during the night. Two periods of
Average fraction of dimerised phosphorylated STAT5 in the  nucleus (DpSnc,tr) (norm. units versus the total amount of Epo  (Epotot) provided during the transient stimulation Figure 6
Average fraction of dimerised phosphorylated 
STAT5 in the nucleus (DpSnc,tr) (norm. units versus 
the total amount of Epo (Epotot) provided during the 
transient stimulation. The system was analysed for tran-
sient stimulation with total amount of Epo Epotot ∈ [10-8,106] 
units/ml. The solid black line is used to highlight the different 
values of DpSnc,tr obtained for a total amount of Epo of one 
hundred units. In this case the average of the system 
response ranges between 0.05 and 0.17 normalised units. 
The dashed black line is used to highlight how in the interval 
of intense stimulation input signals with totally different prop-
erties (Epotot ∈ [101,105] units/ml) produce output signal with 
identical average intensity DpSnc,tr.
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Average fraction of dimerised phosphorylated STAT5 in the  nucleus (DpSnc,tr) (norm. units), during transient stimulation Figure 5
Average fraction of dimerised phosphorylated 
STAT5 in the nucleus (DpSnc,tr) (norm. units), during 
transient stimulation. The behaviour of the system was 
analysed for transient stimulation with an average duration of 
TEpo ∈ [0.1, 104] minutes, and an average concentration of 
Epotr ∈ [10-6,500] units/ml.BMC Systems Biology 2008, 2:38 http://www.biomedcentral.com/1752-0509/2/38
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transition are described that we adopted to describe the
oscillatory signals used in our simulations. The oscilla-
tions in the input signal were characterised by two prop-
erties: the period of the oscillatory signal (T) which is the
time between two consecutive maxima, and the average
value of Epo during the oscillation (Epoosc). The average
value of pEpJ (pEpJosc) and DpSnc (DpSnc,osc) during the
oscillation were defined and computed (Sup. Mat. A7 [see
Additional file 1]). Our analysis suggested that the average
of the signals for a number of periods between eight and
twelve is sufficient to avoid the transient behaviour from
the start of the simulations. We explored the performance
of the system for oscillations with a period between half a
minute and one day and with Epoosc in the interval stud-
ied in the previous cases ([10-6,10] units/ml). Figure 8
shows the results obtained for DpSnc,osc (Sup. Mat. A7 con-
tains figures for pEpJosc [see Additional file 1]).
In Figure 8, we can see that the maximum response of the
system for DpSnc is reached for oscillatory signals with a
period of 5–50 minutes and an average intensity between
0.1 and one (DpSnc ≈ 0.15). This time interval coincides
with the time scale suggested in [14] for the nucleocyto-
plasmic shuttling of STAT5, which could indicate a cou-
pling between the frequency of the oscillations and the
maximum performance of the pathway. For intense stim-
uli with longer period, the system reached a plateau in the
average activated STAT5 in the nucleus at a value of half
the maximum (DpSnc ≈ 0.075). In case of the logarithmic
amplification (Figure 9), a plateau with the highest value
of amplification appears for oscillations with periods
from short to long (T between 10–1000 min.) and weak
stimuli (Epoosc < 10–3). Again, the maximum sensitivity
to changes in the properties of the input signal appears for
intermediate, physiologically feasible Epo concentration
(Epoosc) and for oscillations with a period T of 5–50 min-
utes. Intense stimulation with a short period produces a
minimum in the amplification of the system, although
the system is still strongly activated.
Interestingly, the properties of responsiveness and ampli-
fication predicted by the model with variable non-integer
kinetic orders are very similar to the ones discussed here
(Sup. Mat. A7 contains figures comparing both models
[see Additional file 1]). The sigmoid-like curve on the
responsiveness (DpSnc) for sustained stimulation appears
also for this model but is steeper and appears shifted one
order of magnitude to higher values of sustained stimulus
(Figure A7.1 [see Additional file 1]). Surprisingly, the log-
arithmic amplification (LA) in both models differs for
very small sustained stimulus: the model with fixed prede-
fined integer kinetic orders predicts a small variation on
the values of the amplification through the whole interval
of Epo values whereas the one with variable non-integer
kinetic orders predicts an intense loss of amplification,
Average fraction of dimerised phosphorylated STAT5 in the  nucleus (DpSnc,osc) (norm. units) during oscillatory stimulation Figure 8
Average fraction of dimerised phosphorylated 
STAT5 in the nucleus (DpSnc,osc) (norm. units) during 
oscillatory stimulation. The simulated data was averaged 
for several following periods. The behaviour of the system 
was analysed for oscillatory stimuli with an average period 
duration T ∈ [0.5, 1440] minutes, and an average concentra-
tion of Epoocs ∈ [10-6, 10] units/ml. In all the simulations, the 
signal was averaged for 12 periods of the oscillatory stimulus.
Logarithmic amplification, LA (log. units, see Equation 7.1),  measured for different transient stimuli Figure 7
Logarithmic amplification, LA (log. units, see Equa-
tion 7.1), measured for different transient stimuli. LA 
measures the signal amplification between pEpJ and DpSnc. 
The behaviour of the system was analysed for transient stim-
ulation with an average duration of TEpo ∈ [0.1, 104] minutes, 
and an average concentration of Epotr ∈ [10-6,500] units/ml.
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which becomes negative (signal attenuation) for Epo ≤ 10-
5 units/ml. Our analysis suggests that this feature is shared
by the best power-law solutions (first ten of the selected
power-law solutions, all them with steep sigmoidal
curves). The other power-law solutions have a LA curve
similar to the one obtained for the selected model (data
not shown).
When transient stimulation is analysed, both models pre-
dict a similar shape for the surface accounting for the
responsiveness and logarithmic gain of the system with
respect to the features of the transient stimulation (Epotr,
TEpo), but again the sigmoidal curve for the model with
variable non-integer kinetic orders is steeper and shifted
(Sup. Mat Figure A7.2 [see Additional file 1]). The behav-
iour of the chosen model for oscillatory signals repro-
duces the features of the previously analysed signals (Sup.
Mat Figure A7.3 [see Additional file 1]).
Finally, recent studies suggest the time-dependent recruit-
ment of phosphatases like SHP-1 and other negative reg-
ulators like SOCS proteins as possible mechanisms to
control cytokine responses, in particular in the pathway
studied [28]. Any attempt to understand the behaviour of
the JAK2-STAT5 pathway in depth requires to integrate the
effect of these regulatory proteins in the mathematical
model proposed and to generate the adequate experimen-
tal data to characterise these effects. The results that we
show in this article should be confirmed or refined with
this extended (feedback loop-controlled) model, addi-
tional experimental data and validation.
Conclusion
A mathematical model based on ordinary differential
equations and represented in power-law terms was devel-
oped for the JAK2-STAT5 pathway. Since the data availa-
ble were rather limited, a strategy to reduce the complexity
of the model was formulated following the strategy pro-
posed in [15]. Using the available biological knowledge,
several terms in the models were approximated by con-
ventional kinetic terms with kinetic orders equal to one.
With the remaining kinetic orders, a strategy of gradually
increasing complexity in the structure of the model was
used, which allowed a higher number of kinetic orders to
be different to one for each iteration. The inclusion of a
time delay in the STAT5 cycling was also considered.
Although the best numerical fit to the data was obtained
for a model with variable non-integer kinetic orders, a
compromise between satisfactory reproducibility of
experimental data and reduced complexity of the model
lead to a simpler model with fixed predefined integer
kinetic orders.
The responsiveness and amplification of the system were
studied for sustained, transient, and oscillatory stimuli.
Regarding responsiveness, we focussed on the value of
activated STAT5 in the nucleus (DpSnc), while the analysis
of the fraction of activated receptors has been included in
Sup. Mat. A7 [see Additional file 1]. To measure the ability
of the system to amplify the signal we defined the loga-
rithmic amplification (LA) as the logarithm of the ratio
between the total amount of activated STAT5 in the
nucleus (DpSnc) and the activated receptor (pEpJ) during
the analysed processes. A scale of values was set up in
which positive values imply amplification of the signal,
while negative values imply attenuation.
For the fraction of activated dimerised STAT5 in the
nucleus (DpSnc) and the logarithmic amplification (LA)
the system seems especially sensitive in the range of phys-
iological Epo concentrations [26]. Within this range
changes in the properties of the stimulus for the three
kinds of signals studied (sustained, transient, and oscilla-
tory) provoke significant changes in the response of the
system. For a stronger stimulus the system reaches satura-
tion, while for a weaker stimulus there is no significant
response (the system stays almost switched off). This
could imply that the system is designed to have the maxi-
mum sensitivity to the intensity of the stimuli within the
biologically feasible interval. The highest sensitivity of the
system is not reached for transient stimulation or oscilla-
tory input signals with very long duration (higher than
Logarithmic amplification, LA (log units, see Equation 7.1),  measured for different oscillatory stimuli Figure 9
Logarithmic amplification, LA (log units, see Equa-
tion 7.1), measured for different oscillatory stimuli. 
LA measures the signal amplification between pEpJ and DpSnc. 
The simulated data was averaged for several subsequent peri-
ods. The behaviour of the system was analysed for oscillatory 
stimuli with an average period duration T ∈ [0.5, 1440] min-
utes, and an average concentration of Epoosc ∈ [10-6, 10] 
units/ml. In all the simulations, the signal was averaged for 12 
periods of the oscillatory stimulus.
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one hundred minutes in both cases) but for intermediate
values ([1,102] min). Thus, the system is set up to maxi-
mally respond to rapid changes in the environment but
not to the long day and night oscillations registered under
physiological conditions. Interestingly, the model pre-
dicts a small range of logarithmic amplification values
(LA≈ 2), which means that the average amount of STAT5
units activated per activated receptor remains very similar
(around one hundred units) for a wide interval of Epo
concentrations.
The system acts as a strong amplifier with respect to the
scale defined in the three kinds of processes simulated and
analysed. The model predicts that on average one acti-
vated dimeric EpoR can provoke the activation and subse-
quent nuclear translocation of approximately one
hundred molecules of STAT5. Another interesting prop-
erty is that the system seems to be more efficient when
weak stimuli are applied.
For each model structure analysed, we stored a large col-
lection of solutions and then analysed their properties.
We found that, although the fitting to the data was not
completely satisfactory in some of these solutions, a sig-
nificant part of them showed similar properties related to
the responsiveness and amplification of the system. Both
type of models analysed (fixed predefined integer versus
variable non-integer kinetic orders) show the characteris-
tic sigmoid response curve, but there is a significant differ-
ence between them when the population of the solutions
is considered. For the model with fixed integer kinetic
orders there is a little variation between the 100 best solu-
tions. On the other hand, for the the power-law model
with variable non-integer kinetic orders there is a variety
of solutions that reproduce sigmoid response curves
including those of the model (as shown in Sup. Mat. A8
[see Additional file 1]). We think that this property relates
to the results shown in [29], where the authors suggested
that key properties of the biochemical networks, includ-
ing signalling pathways, should be at least partially robust
(in the sense of not-requiring "fine-tuning" of parame-
ters) in order to ensure their proper functioning. With
regard to this idea, we think that the sigmoid response
curve obtained for the JAK2-STAT5 pathway mostly relates
to the structure of the pathway and not to the precise val-
ues of the model parameters. In this case, the JAK2/STAT5
could be considered as a robust amplifier.
The final conclusion is that the JAK2/STAT5 system acts as
an amplifier of the signal, which has the maximum sensi-
tivity for input signals whose intensity coincides approxi-
mately with the physiological values, and reaches
saturation for very intense and long stimulation. The gen-
eral concepts, definitions and strategy of analysis pro-
posed here could in principle be used to analyse the
properties of any pathway once the dynamics of their reg-
ulatory proteins are measured.
Methods
Experimental techniques
Phoenix-eco cells were transiently transfected with the ret-
roviral expression vector pMOWS-HA-EpoR by calcium-
phosphate as previously described [30]. Six hours after
transfection, Phoenix-eco cells were cultured in Iscove's
Modified Dulbecco's Medium (IMDM) (Invitrogen) con-
taining 50 μM β-mercaptoethanol (Invitrogen) and 30%
fetal calf serum (Invitrogen). Virus-containing superna-
tant was harvested 24 h after transfection and filtered
(0.45-μm filter, Corning). For spin infection, 105 BaF3
cells were transduced with viral supernatants supple-
mented with 8 μg/ml Polybren (Sigma-Aldrich). BaF3
cells stably expressing HA-EpoR were selected in 1.5 μg/
ml puromycin (Sigma-Aldrich) 48 hours after transduc-
tion.
For measuring activated Epo receptor and STAT5, HA-
EpoR-BaF3 cells were starved in RPMI 1640 (Invitrogen)
and 1 mg/ml BSA (Sigma-Aldrich) for 5 h. Cells were stim-
ulated with 5 units/ml Epo (Janssen-Cilag) at 37°C for
indicated times and 107 cells per time point were lysed
with NP-40 lysis buffer (1% NP-40, 150 mM NaCl, 20
mM Tris pH7.4, 10 mM NaF, 1 mM EDTA pH 8.0, 1 mM
ZnCl2 pH4.0, 1 mM MgCl2, 1 mM Na3VO4, 10 % glycerol)
supplemented with aprotinin and AEBSF (Sigma-
Aldrich). For immunoprecipitation, lysates were incu-
bated with anti-EpoR antibodies (Santa Cruz) and anti-
STAT5 antibodies (Santa Cruz). 40 ng of GST-EpoR and
36 ng GST-STAT5b was added as calibrator to each lysate
as described [4]. Immunoprecipitated proteins were
loaded in randomised fashion on SDS polyacrylamide gel
as described [4], separated by electrophoresis and immu-
noblotted using anti-phosphotyrosine monoclonal anti-
body 4G10 (Upstate Biotechnology) and secondary HRP
coupled anti-mouse antibody (Amersham Biosciences).
Immunoblots were incubated with ECL substrate (Amer-
sham Biosciences) for 1 min and exposed for 10 min on a
LumiImager (Roche Diagnostics). LumiAnalyst software
(Roche Diagnostics) was used for quantification. Anti-
bodies were removed by treating the blots with β-mercap-
toethanol (Sigma-Aldrich) and SDS (Serva) as described
[31]. Reprobes were performed using anti-EpoR antibody
(Santa Cruz) and anti-STAT5 antibody (Santa Cruz).
Quantitative immunoblotting data was processed using
GelInspector software [3]. Normalisers GST-EpoR for
pEpoR and GST-STAT5b for pSTAT5 were used. For first
estimates, csaps-splines were used with a smoothness of
0.3 for pEpoR and pSTAT5.
For measuring the extracellular Epo, an independent
experiment was performed in which BaF3 cells stablyBMC Systems Biology 2008, 2:38 http://www.biomedcentral.com/1752-0509/2/38
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expressing murine EpoR were starved in RPMI 1640 (Inv-
itrogen) supplemented with 1 mg/ml BSA (Sigma-
Aldrich) for 3 h and subsequently stimulated for up to
180 min with 5 units/ml [125I]-Epo (Amersham Bio-
sciences) at a density of 4 × 106 cells/100 μl medium and
37°C. To separate free [125I]-Epo from cell-associated
[125I]-Epo, cells were centrifuged through a layer of fetal
calf serum (Invitrogen) and supernatants were measured
in a gamma counter (Packard). Measurements were per-
formed in triplicates. As control, cells were additionally
incubated with an excess of unlabeled Epo (100 units/ml)
(Janssen-Cilag), showing no decrease in free [125I]-Epo in
the medium.
Mathematical modelling
The JAK2-STAT5 pathway has been modelled using a
power-law representation [15]. As we discussed in Back-
ground, power-law models allow the representation of
complex dynamics such as saturation-like behaviour,
inhibition or cooperativity with simplified equations. Our
strategy is to iteratively increase the complexity of our
model by allowing variable non-integer kinetic orders for
those processes where we do not have prior knowledge to
determine the value of the kinetic order. We thus allow for
a larger class of models, which includes the structure of
conventional models based on mass-action kinetics (with
fixed predefined integer kinetic orders) as a special case.
Parameter estimation
In the present paper a genetic algorithm was used for
parameter estimation. The algorithm has been adapted
and optimised for power-law models. In the estimation
process, each element of the population of solutions rep-
resents a point in the parameter value space. The initial
population of solutions is generated through a random
exploration of the search space, which is defined using
feasible intervals of values for the variables (Sup. Mat. A2
[see Additional file 1]). The best individuals of the popu-
lation are selected in the considered iteration based on the
value of the following objective function [32]:
where nexp is the number of experiments, nvar is the number
of measured quantities (observables), ntp the number of
time points where each observable was measured, Xk, j(ti)
the value of the jthobservable at the ith time point obtained
after numerical integration of the solution for the kth
experiment.   is the value of the jth observable at
the ith time point measured in the kth experiment. An addi-
tional fast-climbing stochastic algorithm is applied to the
best solution each iteration of the algorithm. The stopping
criterion is based on either a previously established maxi-
mum number of iterations or a minimum level of satisfac-
tion for the objective function. Computations were
performed on a Sun Fire V880 Server (four processors
UltraSPARC-III, 1200 MHz, 8 MB cache each; RAM mem-
ory 32 GB). The algorithm for parameter estimation was
implemented in Matlab R14 (The Mathworks, Inc. Natick,
MA) running under SunOS 5.10.
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